Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept Bone Effects in Psoriatic Arthritis (ABEPSA_BB)
NCT04106804Phase 4Unknown
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jun 2018
- Primary completion
- Aug 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in psoriatic arthritis (PsA), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Status: unknown.
02
Drugs
abatacept
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT04106804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04106804.